Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic.
about
Prospective evaluation of analgesic use and risk of renal cell cancerNon-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic reviewRegular use of analgesics is a risk factor for renal cell carcinomaPro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cellsFrequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adultsMolecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell linesIn vivo regulation of MAP kinases in Ratus norvegicus renal papilla by water loading and restrictionThe renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly.Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studiesDehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells.A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study.Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation.Variable use of opioid pharmacotherapy for chronic noncancer pain in Europe: causes and consequences.Choosing and using non-steroidal anti-inflammatory drugs in haemophilia.Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines.Drug nephrotoxicity: an overview.Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity.Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.Differential effects of the nonsteroidal antiinflammatory drug flurbiprofen and its nitric oxide-releasing derivative, nitroflurbiprofen, on prostaglandin E(2), interleukin-1beta, and nitric oxide synthesis by activated microglia.Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III).Use of structured self-monitoring in transplant education.A center-based approach to a transplant employment program.
P2860
Q24608512-A785B889-5ABB-427F-A0F7-7B660097434EQ27000437-6BC5A094-1C0A-44EF-A76F-212341D043F1Q28162607-FE8CAEB2-B429-453A-9D40-C335DFBC795BQ28191591-CA716C44-A3FC-4F6B-A248-76F51661CC67Q28213637-D1EFEB66-7806-4868-8E14-EC8DAF63E61EQ28217974-EB193673-DC9B-40C9-9698-3D8DEA9F9FC1Q28770152-E3E29B10-48B9-4CEF-96D2-D08C3C1471FEQ33633390-B86514F1-E87D-4DBD-85D6-7C053BF6BB8AQ34327296-A6BBD45D-F357-452C-AE6A-0FCBF542D8B9Q35127418-98E9BDFE-A5E6-4815-B0EF-F1E5CDE318AFQ35800256-10F1D851-7DCE-4D6D-B366-7FCD4573350CQ37372211-97CA6610-FC7C-471D-A07D-FFA5BE60EBAAQ37641344-3CCCB895-6EFA-4D14-9D1D-A453AC9CDAEAQ38625670-7907E787-1542-478C-BD42-553A917054DBQ40526445-3C7DA7AA-CA3F-451D-8A21-E2D9778AB0BEQ41431134-4335D04D-1F40-42E1-9C78-EE64716DBDA2Q42463008-F3F6A904-6974-487A-917C-8099500BAAA1Q42930380-5ACCE84A-38D7-419B-AF5D-BDD34D137920Q43825314-ABB5FBD1-0CC1-48BA-BBB9-F8FD041BB3FAQ47824106-FC325046-487C-479E-8F24-F0D4668B66D7Q53450064-05B5D9E0-BE78-4121-972A-8E3EF05E943DQ53495935-FC40F95A-6F9E-4D95-85B4-828C0E69C559
P2860
Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Chronic renal disease and papi ...... sole or predominant analgesic.
@en
Chronic renal disease and papi ...... sole or predominant analgesic.
@nl
type
label
Chronic renal disease and papi ...... sole or predominant analgesic.
@en
Chronic renal disease and papi ...... sole or predominant analgesic.
@nl
prefLabel
Chronic renal disease and papi ...... sole or predominant analgesic.
@en
Chronic renal disease and papi ...... sole or predominant analgesic.
@nl
P2093
P1476
Chronic renal disease and papi ...... sole or predominant analgesic.
@en
P2093
Bennett WM
Segasothy M
Zulfigar A
P356
10.1016/S0272-6386(12)80155-7
P577
1994-07-01T00:00:00Z